Barclays downgraded R1 RCM to Equal Weight from Overweight with an unchanged price target of $14. Yesterday’s $13.75 per share takeout bid from NMC accelerated the Overweight thesis, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on RCM:
- R1 RCM to Discuss Quarterly and Annual Financial Results
- R1 RCM Reports Fourth Quarter and Full Year 2023 Results
- R1 RCM downgraded to Hold from Buy at Deutsche Bank
- Coliseum Capital says New Mountain bid indication undervalues R1 RCM
- RBC says $13.75 a ‘reasonable starting point,’ R1 RCM fair value closer to $19
